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Background: Previous research has suggested that vitamin D and sunlight are related to cardiovascular outcomes,
but associations between sunlight and risk factors have not been investigated. We examined whether increased
sunlight exposure was related to improved cardiovascular risk factor status.
Methods: Residential histories merged with satellite, ground monitor, and model reanalysis data were used to
determine previous-year sunlight radiation exposure for 17,773 black and white participants aged 45+ from the
US. Exploratory and confirmatory analyses were performed by randomly dividing the sample into halves. Logistic
regression models were used to examine relationships with cardiovascular risk factors.
Results: The lowest, compared to the highest quartile of insolation exposure was associated with lower
high-density lipoprotein levels in adjusted exploratory (−2.7 mg/dL [95% confidence interval: −4.2, −1.2]) and
confirmatory (−1.5 mg/dL [95% confidence interval: −3.0, −0.1]) models. The lowest, compared to the highest
quartile of insolation exposure was associated with higher systolic blood pressure levels in unadjusted exploratory
and confirmatory, as well as the adjusted exploratory model (2.3 mmHg [95% confidence interval: 0.8, 3.8]), but not
the adjusted confirmatory model (1.6 mg/dL [95% confidence interval: −0.5, 3.7]).
Conclusions: The results of this study suggest that lower long-term sunlight exposure has an association with
lower high-density lipoprotein levels. However, all associations were weak, thus it is not known if insolation may
affect cardiovascular outcomes through these risk factors.
Keywords: Sunlight, Temperature, Weather, Climate, Environment, Blood pressure, Lipids and lipoproteinsBackground
Cardiovascular health varies with season, weather, and
climate [1-3]. While seasonal temperature variation has
been a primary target of investigation, sunlight also varies
seasonally and has not been adequately investigated. Sun-
light directly alters vitamin D status, but aside from skin
cancer there are few data on how sunlight directly affects
human health [4-6]. Although there are few studies of
vitamin D and stroke, there is indication that vitamin D
insufficiency may increase vascular event risk factors
[4,5,7]. Both geographic latitude and vitamin D level have* Correspondence: lmcclure@uab.edu
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unless otherwise stated.been linked to blood pressure, with potential mechanisms
involving the renin-angiotensin system, inflammation,
vasculature, or glycemic control [8,9]. Exposure to ultra-
violet B radiation has also been shown to affect blood
pressure and other stroke risk factors [7,8,10]. Vitamin D
and cholesterol have a common upstream metabolite
7-dehydrocholesterol, which is converted to previtamin
D3 in the skin after exposure to sunlight [11]. Observa-
tional studies have shown that higher vitamin D blood
levels may improve lipid levels [12]. Higher vitamin D
levels may also improve health status of those with
chronic kidney disease, although the results are mixed
[13]. Inflammation is related to stroke, blood pressure,
lipid levels, and kidney function, and may also be related
to vitamin D levels [14-16]. There are seasonal variationsd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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and allergy [16,17]. Vitamin D may also improve kidney
function by acting as renin-angiotensin system inhibitors
[18] and improving microalbuminuria [19].
Sunlight radiation and temperature are available from
the North American Land Data Assimilation System
Phase 2 (NLDAS-2) forcing. These data were matched
to an individual’s geocoded home residence and have
previously been used in the REasons for Geographic
And Racial Differences in Stroke (REGARDS) study,
finding that reduced sunlight exposure was associated
with increased stroke incidence [20]. In this manuscript,
we examine whether increased residential sunlight expos-
ure is related to increased blood pressure, serum lipid
levels, kidney function, and inflammation. Since both skin
color and the kidney are linked with vitamin D production
and regulation [21,22], and since Vitamin D levels have
been posited to contribute to racial health disparities [23],
we examine whether increased sunlight radiation exposure
leads to poorer outcomes among black participants and
those with impaired kidney function. To account for
the multiple hypotheses we are testing, we perform a
split-sample replication analysis. The large size of the
REGARDS cohort allows us to split the participants
into two samples: a hypothesis-generating sample to
explore possible significant relationships, and a confirma-
tory sample to independently assess the associations found
in the exploratory analyses, reducing the likelihood of
Type I error. We hypothesize that increased sunlight
exposure is related to improved cardiovascular risk factor




REGARDS is a longitudinal study of United States (US)
participants aged 45 years and older [24]. The REGARDS
study was designed to investigate reasons underlying the
higher rate of stroke mortality among blacks, compared
with non-Hispanic whites, and among residents in the
Southeastern United States, compared with other US
regions. At baseline, 56% of the participants were residing
in the stroke belt (an area of the US with high stroke mor-
tality in the Southeast including GA, NC, SC, AL, TN,
LA, AR, MS), with the remaining 44% from the rest of the
contiguous 48 US. Participants from the stroke buckle
(an even higher stroke mortality region comprised of
the coastal plains of NC, SC, and GA) comprised 21% of
the REGARDS population. The cohort population at
baseline was 42% African-American/58% white and 45%
male/55% female. Further details on the study are avail-
able elsewhere [24]. The REGARDS study and the
current analysis were approved by the Institutional
Review Boards of participating institutions.Data collection
At baseline, a telephone interview was conducted during
which informed consent was obtained and the partici-
pant’s self-reported demographic and behavioral factors,
and medical history were recorded. Participants were
then visited in their homes by a trained health profes-
sional who collected blood pressure, height, weight,
blood, urine, and conducted electrocardiograms (ECGs),
and obtained written informed consent. Blood and urine
were sent to a central repository at the University of
Vermont and ECG data were read at Wake Forest Univer-
sity. The examiner also left a residential history form to fill
and mail.
Assessment of sunlight exposure and temperature
We used data from the National Aeronautics and Space
Administration (NASA) – National Oceanic and Atmos-
pheric Administration (NOAA) NLDAS-2 dataset to
determine sunlight radiation and temperature. The
NLDAS-2 dataset is based on model reanalysis data and
remotely-sensed and ground observations, and consists
of a grid surface with ~14 km resolution over North
America [25]. NLDAS-2 solar radiation that was assessed
at one-hour intervals was used to calculate a daily total
referred to herein as daily “insolation” [26]. For this study,
we merged daily insolation and maximum air tempera-
tures with data from REGARDS’ residential history form,
which consists of locations where the participant had lived
prior to enrollment into REGARDS, along with age when
relocating. Each location the participant recorded was
matched to a feature in the US Geological Survey’s Geo-
graphic Names Information System using ArcGIS 9.3. For
participants who had a period of missing residential data,
due to having an unidentifiable location or residence
outside of the contiguous 48 United States, we used only
the existing residential history to compute environmental
exposure averages. We assumed participants moved
during July of the indicated moving year.
As in our previous studies, we calculated each month’s
average daily insolation and temperature exposure at
each participant’s residential location to estimate each
participant’s average exposure for the year previous to
baseline [20,27]. We then categorized insolation and
temperature exposure into quartiles. In order to capture
extreme exposures, we also categorized insolation and
temperature exposure using cutpoints at the 5th and 95th
percentiles.
Outcomes
Blood pressure was measured during the REGARDS in-
home visit by a trained technician using a standard protocol
and regularly tested aneroid sphygmomanometer and was
calculated as an average of two measurements taken after





















Figure 1 Eligibility flowchart for participants included in the
analysis of sunlight and cardiovascular risk factors.
Kent et al. BMC Neurology 2014, 14:133 Page 3 of 9
http://www.biomedcentral.com/1471-2377/14/133was defined as present with self-reported use of antihyper-
tensive medications, systolic blood pressure (SBP) ≥ 140
mm Hg, or a diastolic blood pressure (DBP) ≥ 90 mm Hg.
Blood was collected during the in-home visit, and shipped
to the central laboratory at the University of Vermont using
standard protocols. Standard assays were used to determine
lipid levels and high-sensitivity C-reactive protein (CRP)
assays were used to determine the level of CRP, which was
log transformed due to a skewed distribution. CRP levels
were categorized into low/medium risk (CRP ≤ 3 mg/dL)
and high risk (CRP > 3 mg/dL). Dyslipidemia was defined
as present with self-reported use of lipid-lowering medica-
tion, total cholesterol ≥ 240 mg/dL, low-density lipoprotein
(LDL) ≥ 160 mg/dL, or high-density lipoprotein (HDL) ≤
40 mg/dL. Kidney function was determined by the esti-
mated glomerular filtration rate (eGFR) computed using
the CKD EPI equation (participants with eGFR < 60 classi-
fied as having impaired kidney function) [28].
Statistical methods
Because some confounders had missing data for large
numbers of participants, we attempted to minimize
selection bias by creating a separate “missing” category
for any variable that had >1,000 participants missing
data. Participants were excluded due to data anomalies,
stroke or coronary heart disease at baseline, missing resi-
dential history, and missing confounder data (for those
will <1,000 participants missing data). Of the 30,239
participants enrolled at baseline, 17,773 participants were
available for analyses (Figure 1).
To perform a split-sample replication analysis we
randomly assigned the eligible participants into one of
two samples of equal size. In the first “exploratory” sam-
ple, we ran multivariable logistic or linear regression
models adjusting for temperature, age, race, region (stroke
belt, stroke buckle, or non-stroke belt), gender, education
(less than high school, high school graduate, some
college, or college graduate), income (<$20,000, $20,000
to $34,999, $35,000 to $74,999, or ≥ $75,000), quartiles of
vitamin D intake, exercise (none, 1 to 3 times/week, or ≥ 3
times/week), alcohol use (none, moderate: ≤ 1 drink per
day for women or ≤ 2 drinks per day for men, or
heavy: > 1 drink per day for women and > 2 drinks
per day for men), smoking status (current, past, or never)
and body mass index (<18.5, 18.5 to 24.9, 25 to 29.9,
or ≥ 30). We also adjusted for statin use in models with
cholesterol, HDL, or LDL as the outcome, and adjusted
for antihypertensive medication use in the models with
SBP as the outcome. Using interaction terms in fully
adjusted models, we tested for multiplicative interactions
between insolation and each of race or impaired kidney
function on our outcome variables. In the second “con-
firmatory” sample, we re-ran all models for outcomes with
significant associations in the explanatory sample.This study was approved by Institutional Review Boards
of participating institutions.
Results
Exploratory and confirmatory samples
The exploratory (n = 8886) and confirmatory (n = 8887)
samples did not significantly differ by most variables
(Table 1; Additional file 1: Table S1). The exception is that
the confirmatory sample had a higher proportion of males,
although the difference in proportions was only 2.1%
(p = 0.0041).
Systolic blood pressure
Exploratory analyses found monotonic associations be-
tween quartiles of insolation; the lowest, compared to the
highest quartile of insolation exposure was associated with
3.5 and 2.3 mmHg higher SBP for unadjusted and fully
adjusted models, respectively (Table 2). Confirmatory
models replicated this association in the unadjusted
model, but the adjusted confirmatory model was not
significant. In exploratory analyses insolation significantly
interacted with race (Table 3); blacks had stronger associa-
tions in both unadjusted and adjusted exploratory models.
Blacks, compared to whites, also had a stronger associa-
tion between insolation and SBP in the confirmatory
unadjusted model, but not in the confirmatory adjusted
Table 1 Meteorological and secondary stroke endpoint distributions by insolation exposure in the exploration (n = 8886)
and confirmatory (n = 8887) samples
Characteristic Exploratory sample Confirmatory sample P-value
Quartiles of insolation, n (%)
1st (12327 to 15565 KJ/m2/day) 2207 (24.8%) 2236 (25.2%)
2nd (15565 to 16724 KJ/m2/day) 2180 (24.5%) 2263 (25.5%) 0.22
3rd (16724 to 17724 KJ/m2/day) 2223 (25.0%) 2220 (25.0%)
4th (17724 to 22733 KJ/m2/day) 2276 (25.6%) 2168 (24.4%)
Maximum Temperature, n (%)
1st quartile (8.5 to 17.8°C) 2206 (24.8%) 2237 (25.2%)
2nd quartile (17.8 to 21.7°C) 2247 (25.3%) 2198 (24.7%) 0.82
3rd quartile (21.7 to 24.0°C) 2224 (25.0%) 2217 (24.9%)
4th quartile (24.0 to 31.7°C) 2209 (24.9%) 2235 (25.1%)
SBP, mean mmHg (SD) 126.5 (16.4) 126.4 (16.0) 0.49
Cholesterol, mean mg/dL (SD) 195.0 (38.2) 194.3 (37.8) 0.25
LDL, mean mg/dL (SD) 116.8 (34.0) 116.3 (33.9) 0.34
HDL, mean mg/dL (SD) 53.3 (16.3) 53.2 (16.1) 0.24
Ln CRP, mean mg/dL (SD) 0.77 (1.16) 0.75 (1.18) 0.17
Hypertensive, n (%) 4847 (54.5%) 4760 (53.6%) 0.19
Dyslipidemia, n (%) 4778 (53.8%) 4718 (53.1%) 0.36
High CRP risk category, n (%) 3511 (39.5%) 3449 (38.8%) 0.3377
Impaired kidney function, n (%) 737 (8.3%) 722 (8.1%) 0.68
n = Number; SD = standard deviation; SBP = Systolic Blood Pressure; LDL = Low-Density Lipoprotein; HDL = High-Density Lipoprotein; CRP = C-reactive protein.
P-values for categorical variables were determined by likelihood-ratio chi-square tests and for continuous variables by ANOVA F-test.
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confirmatory model, insolation was significant and
parameter estimates had similar magnitudes to the un-
adjusted confirmatory model. Insolation exposure <5th
versus ≥5th percentile was significantly associated with
2.4 and 2.5 mmHg higher SBP in exploratory un-
adjusted and adjusted models, respectively. However,
these associations were not significant in confirmatory
analyses.
Total cholesterol, LDL, and HDL
Insolation did not have significant associations with total
cholesterol or LDL in exploratory models (Table 2).
Lower quartiles of insolation exposure were significantly
associated with lower HDL levels in all analyses. The
lowest, compared to the highest quartile of insolation
exposure was significantly associated with 1.3 and
1.5 mg/dL lower HDL levels in adjusted exploratory
and confirmatory models, respectively. Insolation ex-
posure <5th versus ≥5th percentile was associated with
lower HDL levels in the adjusted exploratory, but not
adjusted confirmatory model. Insolation exposure <95th
versus ≥95th percentile was associated with 2.7 mg/dL
lower HDL levels in the adjusted exploratory model,
but this association was not significant in the confirma-
tory model.Continuous C-reactive protein
Quartiles of insolation, and insolation exposure <5th versus
≥5th percentile were each significantly associated with differ-
ences in CRP levels in unadjusted exploratory and confirma-
tory models, but these associations were no longer significant
after adjustment. Insolation exposure <95th versus ≥95th
percentile was not associated with a difference in CRP
levels in any models (Table 2).
Hypertension
Insolation was not significantly associated with hyperten-
sion in any analyses (Table 4).
Dyslipidemia
Insolation was not significantly associated with dyslipidemia
in any main effect models (Table 4). In exploratory models,
insolation exposure <5th versus ≥5th percentile was associ-
ated with an increased risk of dyslipidemia among those
without impaired kidney function, but associated with a de-
creased risk of dyslipidemia among those without impaired
kidney function (Additional file 2: Table S2). However, this
was not replicated in confirmatory models.
High levels of C-reactive protein
Quartiles of insolation exposure were significantly associ-
ated with high CRP in the unadjusted exploratory model
Table 2 Differences in continuous secondary cardiovascular endpoints associated with residential insolation exposure
in exploratory and confirmatory analyses
Insolation exposure SBP (mmHg) Total cholesterol (mg/dL) LDL (mg/dL) HDL (mg/dL) LnCRP (mg/dL)
Quartiles of insolation exposure
Exploratory analyses – Unadjusted
1st vs 4th quartile 3.5 (2.6, 4.5) 1.5 (−0.7, 3.8) 2.4 (0.5, 4.4) −1.3 (−2.2, −0.3) 0.0 (−0.1, 0.0)
2nd vs 4th quartile 2.3 (1.4, 3.3) 0.3 (−1.9, 2.6) 0.8 (−1.2, 2.8) −2.0 (−2.9, −1.0) 0.1 (0.0, 0.1)
3rd vs 4th quartile 1.9 (0.9, 2.9) 0.2 (−2.0, 2.5) 0.4 (−1.6, 2.3) −0.9 (−1.8, 0.1) 0.1 (0.0, 0.2)
Exploratory analyses – Fully adjusted
1st vs 4th quartile 2.3 (0.8, 3.8) −3.1 (−6.6, 0.4) −1.1 (−4.2, 2.0) −2.7 (−4.2, −1.2) 0.0 (−0.1, 0.1)
2nd vs 4th quartile 1.9 (0.8, 3.1) −2.1 (−4.8, 0.7) −0.7 (−3.1, 1.7) −2.0 (−3.2, −0.9) 0.1 (0.0, 0.2)
3rd vs 4th quartile 1.4 (0.4, 2.4) −0.8 (−3.1, 1.5) −0.5 (−2.6, 1.6) −0.6 (−1.6, 0.3) 0.1 (0.0, 0.1)
Confirmatory analyses – Unadjusted
1st vs 4th quartile 3.3 (2.3, 4.2) N/A N/A −0.2 (−1.1, 0.8) −0.1 (−0.1, 0.0)
2nd vs 4th quartile 1.7 (0.8, 2.6) N/A N/A −1.8 (−2.8, −0.9) 0.0 (−0.1, 0.1)
3rd vs 4th quartile 1.8 (0.9, 2.6) N/A N/A −0.6 (−1.6, 0.3) 0.1 (0.0, 0.2)
Confirmatory analyses – Fully adjusted
1st vs 4th quartile 1.6 (−0.5, 3.7) N/A N/A −1.5 (−3.0, −0.1) 0.0 (−0.1, 0.1)
2nd vs 4th quartile 1.1 (−0.5, 2.7) N/A N/A −2.1 (−3.2, −0.9) 0.0 (−0.1, 0.1)
3rd vs 4th quartile 1.4 (−1.0, 1.7) N/A N/A −0.5 (−1.4, 0.6) 0.0 (0.0, 0.1)
Low insolation exposure
<5th vs ≥5th percentile
Exploratory analyses - Unadjusted 2.4 (0.8, 3.9) 0.5 (−3.1, 4.1) 1.3 (−2.0, 4.5) −1.0 (−2.6, 0.5) −0.2 (−0.3, −0.1)
Exploratory analyses – Fully adjusted 2.5 (1.0, 4.1) −0.4 (−4.1, 3.3) 0.9 (−2.4, 4.2) −1.7 (−3.2, −0.1) −0.1 (−0.2, 0.0)
Confirmatory analyses - Unadjusted 1.1 (−0.4, 2.7) N/A N/A −0.1 (−1.6, 1.5) −0.1 (−0.2, 0.0)
Confirmatory analyses – Fully adjusted 0.6 (−1.7, 2.9) N/A N/A 0.0 (−1.7, 1.6) −0.1 (−0.2, 0.0)
High insolation exposure
<95th vs ≥95th percentile
Exploratory analyses - Unadjusted 0.3 (−1.3, 1.9) −1.9 (−5.5, 1.8) 0.4 (−2.8, 3.6) −3.6 (−5.1, −2.0) 0.0 (−0.1, 0.1)
Exploratory analyses – Fully adjusted 0.2 (−1.4, 1.7) −2.7 (−6.3, 1.0) 0.0 (−3.2, 3.2) −2.7 (−4.2, −1.2) −0.1 (−0.2, 0.0)
Confirmatory analyses - Unadjusted N/A N/A N/A −1.7 (−3.3, −0.2) N/A
Confirmatory analyses – Fully adjusted N/A N/A N/A −1.5 (−3.1, 0.0) N/A
SBP = Systolic Blood Pressure; LDL = Low-Density Lipoprotein; HDL = High-Density Lipoprotein; CRP = C-reactive protein.
Numbers in parentheses are 95% confidence intervals. Numbers in bold are significant (p < 0.05).
All fully adjusted models are adjusted for temperature, age, race, region, gender, education, income, vitamin D intake, alcohol use, smoking, and body mass index.
SBP models are further adjusted for antihypertensive medication use. Total cholesterol, LDL, and HDL models are further adjusted for statin use. Models with
insolation categorized into quartiles, and using cutoffs at the 5th and 95th percentiles were adjusted for temperature exposures into quartiles and using cutoffs at
the 5th and 95th percentiles, respectively.
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the unadjusted exploratory, insolation exposure <5th versus
≥5th percentile was significantly associated with high CRP.
In unadjusted exploratory models, quartiles of insolation
exposure significantly interacted with kidney impairment
and insolation exposure <5th vs ≥5th percentile significantly
interacted with race (Additional file 3: Tables S3 and
Additional file 4: Table S4). However, no insolation main
effects or interaction terms in exploratory adjusted models
or in any of the confirmatory models were significant.
Kidney impairment
Insolation was not significantly associated with kidney
impairment in any analyses (Table 4).Discussion
This analysis adds to the limited previous research ad-
dressing the relationship between sunlight and vascular
health. Higher myocardial infarction, stroke, and adverse
vascular risk factor rates have been reported in farther
northern latitudes, but it is not clear whether this is due
to environmental, social, or other factors [4,29,30]. There
is also some evidence of higher myocardial infarction and
stroke rates during the winter [1,31] although other re-
search contradicts this [3]. While lower temperatures have
been shown to be associated with high blood pressures
[2,32], there may also be seasonal variations in lipid levels
that are independent of temperature [33]. Sunlight expos-
ure is another seasonal factor, and might affect vascular
Table 3 Differences in systolic blood pressure (SBP) associated with residential insolation exposure in exploratory and
confirmatory analyses, by race
Quartiles of insolation exposure SBP (mmHg)
Blacks Whites p-value
Exploratory analyses – Unadjusted
1st vs 4th quartile 4.7 (3.2, 6.1) 2.4 (1.1, 3.6)
2nd vs 4th quartile 1.4 (−0.1, 3.0) 3.1 (1.9, 4.3) 0.0005
3rd vs 4th quartile 1.3 (−0.2, 2.8) 2.1 (0.9, 3.3)
Exploratory analyses – Fully adjusted
1st vs 4th quartile 3.8 (2.8, 5.6) 1.4 (−0.2, 3.1)
2nd vs 4th quartile 1.1 (−0.5, 2.7) 2.4 (1.0, 3.8) 0.0012
3rd vs 4th quartile 1.2 (−0.2, 2.7) 1.5 (0.2, 2.7)
Confirmatory analyses – Unadjusted
1st vs 4th quartile 4.6 (3.2, 6.1) 1.9 (0.7, 3.1)
2nd vs 4th quartile 1.8 (0.2, 3.3) 1.9 (0.7, 3.0) 0.0058
3rd vs 4th quartile 1.7 (0.2, 3.2) 1.7 (0.5, 2.9)
Confirmatory analyses – Fully adjusted
1st vs 4th quartile 1.7 (−0.7, 4.1) 1.6 (−0.9, 4.1)
2nd vs 4th quartile 0.6 (−1.5, 2.6) 1.6 (−0.4, 3.7) 0.5855
3rd vs 4th quartile −0.3 (−2.3, 1.6) 1.0 (−0.8, 2.8)
Numbers in parentheses are 95% confidence intervals. Numbers in bold are significant (p < 0.05).
All fully adjusted models are adjusted for temperature, age, race, region, gender, education, income, vitamin D intake, alcohol use, smoking, body mass index, and
antihypertensive medication use. Models with insolation categorized into quartiles, and using cutoffs at the 5th and 95th percentiles were adjusted for
temperature exposures into quartiles and using cutoffs at the 5th and 95th percentiles, respectively.
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creasingly found to be related to various chronic diseases.
There is indication that vitamin D insufficiency may in-
crease vascular event risk [34,35] and adversely impact
various vascular risk factors [8]. For most people, vitamin
D status is primarily determined by sunlight exposure
[6,36]. Blood serum 25(OH)D levels are usually used to
determine vitamin D status and can fluctuate with differ-
ential exposure to light and dietary intake.
This study is the third using REGARDS data merged
with NASA meteorological data that demonstrated a
possible link between sunlight and health [20,27]. The
results of this study suggest that lower long-term sun-
light exposure has an association with lower HDL levels,
after accounting for confounders. Since this association
was found in both exploratory and confirmatory models,
it is not likely that this finding is due to chance. How-
ever, the magnitude of this association is small, since
those in the lowest, compared to the highest quartile of
insolation exposure had only about 2 mg/dL lower HDL
levels compared to those with higher sunlight exposures.
In addition, while observational studies have shown that
higher HDL levels are associated with lower cardiovascu-
lar risk, interventional studies have not been consistent
and are ongoing, so the clinical significance of this asso-
ciation is unknown [37]. Sunlight also had significant
univariate relationships with SBP in both exploratory and
confirmatory models, but this association did not remainsignificant after confounder adjustment in the confirmatory
models. In addition, the associations with SBP were also
small, with adjusted effect sizes less than 3 mmHg. We also
found that the association between insolation and SBP may
be stronger among blacks than whites, but this interaction
was also not significant in adjusted confirmatory models.
We determined that this was due to the inclusion of tem-
peratures in the model. Previous research in REGARDS
and other studies have found lower temperatures to be
related to higher blood pressures [38]. It is not clear why
the inclusion of temperature would eliminate the significant
association between insolation and SBP in the exploratory,
but not confirmatory analyses. Collinearity may be an issue,
with higher maximum temperatures correlated with higher
insolation levels. These results agree with our previous ana-
lyses which suggest that decreased sunlight exposure is re-
lated to increased stroke incidence and increased likelihood
of cognitive impairment and decline [20,27,39], although
given the effect sizes it is unlikely that the traditional risk
factors explored fully mediate these associations.
There is little other research examining sunlight and
vascular risk, but a recent Hong Kong study found that
temperature and air pressure, but not solar radiation,
were significantly associated with stroke [40]. Our current
and previous research differs from this study in many
ways, including temporality (exposure within days of
outcome, rather than one year exposure in this analysis),
location (a small tropical area rather than a wide range of
Table 4 Hazard ratios for continuous secondary cardiovascular endpoints associated with residential insolation
exposure in exploratory and confirmatory analyses
Insolation exposure Hypertension Dyslipidemia High CRP Impaired kidney
Quartiles of insolation exposure
Exploratory analyses – Unadjusted
1st vs 4th quartile 1.1 (0.9, 1.2) 1.0 (0.9, 1.1) 0.9 (0.8, 1.1) 0.8 (0.7, 1.0)
2nd vs 4th quartile 1.0 (0.9, 1.2) 1.1 (1.0, 1.2) 1.1 (0.9, 1.2) 0.9 (0.8, 1.2)
3rd vs 4th quartile 1.2 (1.0 (1.3) 1.0 (0.9, 1.2) 1.2 (1.0, 1.3) 0.9 (0.7, 1.1)
Exploratory analyses – Fully adjusted
1st vs 4th quartile 1.2 (0.9, 1.4) 0.9 (0.8, 1.1) 1.1 (0.9, 1.3) 0.8 (0.6, 1.2)
2nd vs 4th quartile 1.0 (0.9, 1.2) 1.0 (0.9, 1.2) 1.2 (1.0, 1.4) 0.9 (0.7, 1.2)
3rd vs 4th quartile 1.1 (0.9, 1.2) 1.0 (0.9, 1.1) 1.1 (1.0, 1.3) 0.9 (0.7, 1.2)
Confirmatory analyses – Unadjusted
1st vs 4th quartile N/A N/A 1.0 (0.8, 1.1) N/A
2nd vs 4th quartile N/A N/A 1.0 (0.9, 1.1) N/A
3rd vs 4th quartile N/A N/A 1.1 (1.0, 1.2) N/A
Confirmatory analyses – Fully adjusted
1st vs 4th quartile N/A N/A 1.1 (0.9, 1.4) N/A
2nd vs 4th quartile N/A N/A 1.0 (0.8, 1.2) N/A
3rd vs 4th quartile N/A N/A 1.0 (0.9, 1.2) N/A
Low insolation exposure
<5th vs ≥5th percentile
Exploratory analyses - Unadjusted 1.0 (0.8, 1.2) 1.1 (0.9, 1.3) 0.8 (0.6, 0.9) 0.8 (0.6, 1.2)
Exploratory analyses – Fully adjusted 1.2 (1.0, 1.5) 1.2 (1.0, 1.5) 0.9 (0.7, 1.1) 0.8 (0.6, 1.3)
Confirmatory analyses - Unadjusted N/A N/A 0.9 (0.7, 1.1) N/A
Confirmatory analyses – Fully adjusted N/A N/A 0.9 (0.7, 1.2) N/A
High insolation exposure
<95th vs ≥95th percentile
Exploratory analyses - Unadjusted 1.0 (0.8, 1.2) 1.2 (1.0, 1.5) 1.0 (0.9, 1.3) 0.8 (0.6, 1.1)
Exploratory analyses – Fully adjusted 0.9 (0.8, 1.2) 1.2 (0.9, 1.4) 0.9 (0.7, 1.1) 0.8 (0.6, 1.2)
Confirmatory analyses - Unadjusted N/A N/A N/A N/A
Confirmatory analyses – Fully adjusted N/A N/A N/A N/A
CRP = C-reactive protein.
Numbers in parentheses are 95% confidence intervals. Numbers in bold are significant (p < 0.05).
Fully adjusted models are adjusted for temperature, age, race, region, gender, education, income, vitamin D intake, alcohol use, smoking, and body mass index.
Models with insolation categorized into quartiles, and using cutoffs at the 5th and 95th percentiles were adjusted for temperature exposures into quartiles and
using cutoffs at the 5th and 95th percentiles, respectively.
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http://www.biomedcentral.com/1471-2377/14/133mostly temperate areas), and that our study did not
include air pressure. Since 25(OH)D3 has a biological
half-life of several weeks [34], it would be plausible that
our longer term sunlight exposure would have a larger
effect on vitamin D levels, and thus on vascular risk. And
while we did not include air pressure in our models, we
did account for temperature, as this is the primary me-
teorological variable that has been shown to have associa-
tions with vascular risk.
Exposure misclassification exists as a possible source
of bias. This could happen if during the time period of
an exposure measurement a participant spent a large
amount of time in a climate different from that indicated
by the outdoor exposures linked to his or her residence.In addition to exposure misclassification, it is possible
that our findings are confounded by spatial autocorrel-
ation, although that is not likely since adding region to
the model did not attenuate the relationship. Another
potential limitation is that there may be confounders for
which we have not accounted, such as air pollution.
While we did not correct for variables such as clou-
diness and altitude, insolation measures represent the
sunlight energy received on the ground, so the effects of
such variables do not need to be included.
Conclusions
This study found a relationship between sunlight exposure
and HDL levels that is not likely due to chance. However,
Kent et al. BMC Neurology 2014, 14:133 Page 8 of 9
http://www.biomedcentral.com/1471-2377/14/133all observed associations were of small magnitudes. More
research is needed to determine whether insolation affects
cardiovascular outcomes through these risk factors.
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